First Oral Immunotherapy for Peanut Allergy
Peanut (Arachis hypogaea) allergen powder-dnfp (Palforzia) is the first oral immunotherapy for children ages four to 17 years who have been diagnosed with a peanut allergy.Like subcutaneous forms of immunotherapy, Palforzia introduces the allergen in increasing doses and risks inducing allergic responses, including anaphylaxis.
Source: AJN - Category: Nursing Tags: Drug Watch Source Type: research
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Children | Immunotherapy | Nursing | Peanuts